Colorectal adenomatous and hyperplastic polyps: Smoking and N- acetyltransferase 2 polymorphisms

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 1, 1999, Pages 69-75

  Potter, John D ^a   Bigler, Jeannette ^a   Fosdick, Lisa ^b   Bostick, Roberd M ^c   Kampman, Ellen ^d   Chen, Chu ^a   Louis, Thomas A ^b   Grambsch, Patricia ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

^d WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RISK; COLON POLYP; COLORECTAL CANCER; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; SMOKING;

ADENOMATOUS POLYPS; ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; CONFIDENCE INTERVALS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPERPLASIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTAGENS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RECTAL NEOPLASMS; SEX FACTORS; SMOKING;

EID: 0032996413     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Potter, J. D., Slattery, M. L., Bostick, R. M., and Gapstur, S. M. Colon cancer: a review of the epidemiology. Epidemiol. Rev., 15: 499-545, 1993.
2. Wynder, E. L., and Shigematsu, T. Environmental factors of cancer of the colon and rectum. Cancer (Phila.), 20: 1520-1561, 1967.
3. Slattery, M. L., West, D. W., Robison, L. M., French, T. K., Ford, M. H., Schuman, K. L., and Sorenson, A. W. Tobacco, alcohol, coffee, and caffeine as risk factors for colon cancer in a low-risk population. Epidemiology, 1: 141-145, 1990.
4. Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., Kearney, J., and Willett, W. C. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US men. J. Natl. Cancer Inst. (Bethesda), 86: 183-191, 1994.
5. Giovannucci, E., Colditz, G. A., Stampfer, M. J., Hunter, D., Rosner, B. A., Willett, W. C., and Speizer, F. E. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in US women. J. Natl. Cancer Inst., 86: 192-199, 1994.
6. Slattery, M. L., Potter, J. D., Friedman, G. D., Ma, K-N., and Edwards, S. Tobacco use and colon cancer. Int. J. Cancer, 70: 259-264, 1997.
7. Knekt, P., Hakama, M., Jarvinen, R., et al. Smoking and risk of colorectal cancer. Br. J. Cancer, 78: 136-139, 1998.
8. Hoff, G., Vatn, M., and Larsen, S. Relationship between tobacco smoking and colorectal polyps. Scand. J. Gastroenterol., 22: 13-16, 1987.
9. Demers, R. Y., Neale, A. V. P. D., Deighton, K., Scott, R. O., Dupuis, M. H., and Herman, S. Serum cholesterol and colorectal polyps. J. Clin. Epidemiol., 41: 9-13, 1988.
10. Kikendall, J. W., Bowen, P. E., Burgess, M. B., Magnetti, C., Woodward, J., and Langenberg, P. Cigarettes and alcohol as independent risk factors for colonie adenomas. Gastroenterology, 97: 660-664, 1989.
11. Kono, S., Ikeda, N., Yanai, F., Shinchi, K., and Imanishi, K. Alcoholic beverages and adenomatous polyps of the sigmoid colon: a study of male self-defence officials in Japan. Int. J. Epidemiol., 19: 848-852, 1990.
12. Zahm, S. H., Cocco, P., and Blair, A. Tobacco smoking as a risk factor for colon polyps. Am. J. Public Health, 81: 846-849, 1991.
13. Monnet, E., Allemand, H., Farina, H., and Carayon, P. Cigarette smoking and the risk of colorectal adenoma in men. Scand. J. Gastroenterol., 26: 758-762, 1991.
14. Cope, G. F., Wyatt, J. I., Pinder, I. F., Lee, P. N., Heatley, R. V., and Kelleher, J. Alcohol consumption in patients with colorectal adenomatous polyps. Gut, 32: 70-72, 1991.
15. Honjo, S., Kono, S., Shinchi, K., Imanishi, K., and Hirohata, T. Cigarette smoking, alcohol use and adenomatous polyps of the sigmoid colon. Jpn. J. Cancer Res., 83: 806-811, 1992.
16. Olsen, J., and Kronborg, O. Coffee, tobacco and alcohol as risk factors for cancer and adenoma of the large intestine. Int. J. Epidemiol., 22: 398-402, 1993.
17. Sandler, R. S., Lyles, C. M., McAuliffe, C., Woosley, J. T., and Kupper, L. L. Cigarette smoking, alcohol, and the risk of colorectal adenomas. Gastroenterology, 104: 1445-1451, 1993.
18. Lee, W. C., Neugut, A. I., Garbowski, G. C., Forde, K. A., Treat, M. R., Wayne, J. D., and Fenoglio-Preiser, C. Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps. Ann. Epidemiol., 3: 239-244, 1993.
19. Martinez, M. E., McPherson, R. S., Annegers, J. F., and Levin, B. Cigarette smoking and alcohol consumption as risk factors for colorectal adenomatous polyps. J. Natl. Cancer Inst. (Bethesda), 87: 274-279, 1995.
20. Kearney, J., Giovannucci, E., Rimm, E. B., Stampfer, M. J., Colditz, G. A., Ascherio, A., Bleday, R., and Willett, W. C. Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum (United States). Cancer Causes Control, 6: 45-56, 1995.
21. Martinez, M. E., McPherson, R. S., Levin, B., and Glober, G. A. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology, 113: 423-429, 1997.
22. Otori, K., Oda, Y., Sugiyama, K., Hasebe, T., Mukai, K., Fujii, T., Tajiri, H., Yoshida, S., Fukushima, S., and Esumi, H. High frequency of K-ras mutations in human colorectal hyperplastic polyps. Gut, 40: 660-663, 1997.
23. Gardner, E. J. A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum. Am. J. Hum. Genet., 3: 167-176, 1951.
24. Lynch, P. M., and Lynch, H. T. Colon Cancer Genetics. New York: Van Nostrand Reinhold, 1985.
25. Aaltonen, L. A., Salovaara, R., Kristo, P., et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J. Med., 338: 1481-1487, 1998.
26. Probst, M., Blum, M., Fasshauer, I., D'Orazio, D., Meyer, Y., and Wild, D. The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo [4,5-f]quinoline (IQ). Carcinogenesis (Lond.), 13: 1713-1717, 1992.
27. Kadlubar, F. F., Butler, M. A., Kaderlik, K. R., Chou, H-C., and Lang, N. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ. Health Perspect., 98: 69-74, 1992.
28. Blum, M., Grant, M., McBride, W., Heim, M., and Meyer, U. Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol., 9: 193-203, 1990.
29. Deguchi, T., Massimo, M., and Suzuki, T. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver. J. Biol. Chem., 265: 12757-12760, 1990.
30. Bell, D. A., Taylor, J. A., Butler, M. A., Stephens, E. A., Wiest, J., Brubaker, L. H., Kadlubar, F. F., and Lucier, G. W. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow acetylator allele common in African-Americans. Carcinogenesis (Lond.), 14: 1689-1692, 1993.
31. Lin, H. J., Han, C. Y., Lin, B. K., and Hardy, S. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics, 4: 125-134, 1994.
32. Vatsis, K. P., Martell, K. J., and Weber, W. W. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proc. Natl. Acad. Sci. USA, 88: 6333-6337, 1991.
33. Woolhouse, N. M., Qureshi, M. M., and Bayoumi, R. A. L. A new mutation C759T in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics, 7: 83-84, 1997.
34. Ferguson, R. J., Doll, M. A., Rustan, T. D., Gray, K., and Hein, D. W. Cloning, expression, and functional characterization of two mutant (NAT2191 and NAT2341/803) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles. Drug Metab. Dispos., 22: 371-376, 1994.
35. Hein, D. W., Ferguson, R. J., Doll, M. A., Rustan, T. D., and Gray, K. Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum. Mol. Genet., 3: 729-734, 1994.
36. Rothman, N., Hayes, R. B., Bi, W., Caporaso, N., Broly, F., Woosley, R. L., Yin, S., Feng, P., You, X., and Meyer, U. A. Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males. Pharmacogenetics, 3: 250-255, 1993.
37. Cascorbi, I., Drakoulis, N., Brockmàller, J., Maurer, A., Sperling, K., and Roots, I. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity. Am. J. Hum. Genet., 57: 581-592, 1995.
38. Cascorbi, I., Brockmoller, J., Bauer, S., Reum, T., and Roots, I. NAT2*12A (803A-> G) codes for rapid arylamine N-acetylation in humans. Pharmacogenetics, 6: 257-259, 1996.
39. O'Brien, M. J., Winawer, S. J., Zauber, A. G., Gotlieb, L. S., Sternberg, S. S., Diaz, B., Dickersin, G. R., Ewing, S., Geller, S., and Kasimian, D. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology, 98: 371-379, 1990.
40. Bigler, J., Chen, C., and Potter, J. D. Determination of human NAT2 acetylator genotype by oligonucleotide ligation assay. Biotechniques, 22: 682-690, 1997.
41. Vatsis, K. P., Weber, W. W., Bell, D. A., Dupret, J. M., Evans, D. A., Grant, D. M., Hein, D. W., Lin, H. J., Meyer, U. A., Relling, M. V., Sim, E., Suzuki, T., and Zamazoe, Y. Nomenclature for N-acetyltransferases. Pharmacogenetics, 5: 1-17, 1995.
42. Potter, J., Bostick, R., Grandits, G., Fosdick, L., Elmer, P., Wood, J., Grambsch, P., and Louis, T. Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota CPRU Case-Control Study. Cancer Epidemiol. Biomark. Prev., 5: 779-784, 1996.
43. Kampman, E., Slattery, M. L., Bigler, J., Leppert, M., Samowitz, W., Caan, B. J., and Potter, J. D. Meat consumption, genetic susceptibility, and colon cancer risk: a multi-center case-control study in the United States. Cancer Epidemiol. Biomark. Prev., 8: 15-24, 1999.
44. Lang, N. P., Chu, D. Z. J., Hunter, C. F., Kendall, D. C., Flammang, T. J., and Kadlubar, F. F. Role of aromatic amine acetyltransferase in human colorectal cancer. Arch. Surg., 121: 1259-1261, 1986.
45. Ilett, K. F., Beverly, M. D., Detchon, P., Castleden, W. M., and Kwa, R. Acetylation phenotype in colorectal carcinoma. Cancer Res., 47: 1466-1469, 1987.
46. Shibuta, K., Nakashima, T., Abe, M., Mashimo, M., Mori, M., Ueo, H., Akiyoshi, T., Sugimachi, K., and Suzuki, T. Molecular genotyping for N-acetylation polymorphism in Japanese patients with colorectal cancer. Cancer (Phila.), 74: 3108-3112, 1994.
47. Roberts-Thomson, I. C., Ryan, P., Khoo, K. K., Hart, W. J., McMichael, A. J., and Butler, R. N. Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet, 347: 1372-1374, 1996.
48. Welfare, M. R., Cooper, J., Bassendine, M. F., and Daly, A. K. Relationship between acetylator status, smoking, diet, and colorectal cancer risk in the northeast of England. Carcinogenesis (Lond.), 18: 1351-1354, 1997.
49. Probst-Hensch, N. M., Haile, R. W., Ingles, S. A., et al. Acetylation polymorphism and prevalence of colorectal adenomas. Cancer Res., 55: 2017-2020, 1995.
50. Probst-Hensch, N. M., Haile, R. W., Li, D. S., Sakamoto, G. T., Louie, A. D., Lin, B. K., Frankl, H. D., Lee, E. R., and Lin, H. J. Lack of association between the polyadenylation polymorphism in the N-acetyltransferase-1 gene (NAT1) and colorectal adenomas. Carcinogenesis (Lond.), 17: 2125-2129, 1996.
51. Lin, H. J., Probst-Hensch, N. M., Hughes, N. C., Sakamoto, G. T., Louie, A. D., Kau, I. H., Lin, B. K., Lee, D. B., Lin, J., Frankl, H. D., Lee, E. R., Hardy, S., Grant, D. M., and Haile, R. W. Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics, 8: 269-281, 1998.